nukliD®: Driving Innovation in Radiopharmacy - From Saxony to the World
Lunch session as part of the European Association of Nuclear Medicine (EANM) in Barcelona
- Ort
- CCIB (International Barcelona Convention Center), VIP Room (Level M1)
- Veranstaltungsdatum
- October 6, 2025; 1:00 - 2:30 PM
- Anmeldeschluss
- Keine Anmeldung erforderlich
- Zielgruppe
- attendees of EANM
- Branchen
- Life Sciences, radiopharmacy
- Land/Region
- Europe, Spain, Germany, Saxony
- Veranstalter
- cluster nukliD® and Saxony Trade & Invest Corp.
- Kosten für die Teilnahme
- free participation
Agenda
Opening
- Introductory Movie
Welcome & Overview
- Introduction to nukliD® / Jens Junker, CEO, ROTOP Pharmaka GmbH
Spotlight on Saxony
- Presentation of Saxony as a Hub for Opportunities / Barbara Weigert, Project Manager Inward Investment, Saxony Trade & Invest
Pitch Session by nukliD® Partners
- ABX advanced biochemical compounds GmbH: Dr. Marco Müller, CEO
- Helmholtz-Zentrum Dresden-Rossendorf (HZDR): Prof. Kopka, Director Institute of Radiopharmaceutical Cancer Research
- TRIMT GmbH: Dr. Johannes Notni, CSO
- ROTOP Pharmaka GmbH: Jens Junker, CEO
- Eckert & Ziegler SE (EZAG): Dr. Gunnar Mann, Board Member
- ABX-CRO advanced pharmaceutical services: Dr. Andreas Kluge, CEO
- CUP Contract Labs: Dr. Dirk Freitag-Stechl, CEO
Interactive Dialogue, Networking & Lunch
Closing
Kontakt
Barbara Weigert
Investor Services
+49-351-2138 153
Termin merken
Lunch session as part of the European Association of Nuclear Medicine (EANM) in Barcelona